Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Non Operating Income (2024 - 2026)

Updated

Adaptin Bio (APTN) recorded Non Operating Income of -$4,696 in Q2 2026.

Analysis

Adaptin Bio (APTN) Non Operating Income (2024 - 2026) Analysis & Trends

On a TTM basis, Adaptin Bio's Non Operating Income came in at -$6,639 as of Jun 30, 2026; for FY2025, it came in at $247,374.

  • Across earlier years, Non Operating Income came in at -$552,672 in FY2024.
  • The Q2 2026 figure is the lowest quarterly Non Operating Income since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Adaptin Bio 56.76 Mn 54.75 Mn - -4,696.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4,696.00
Mar 31, 2026 -1,943.00
Mar 31, 2025 247,374.00
Dec 31, 2024 -348,756.00
Sep 30, 2024 -112,802.00
Jun 30, 2024 -51,418.00
Mar 31, 2024 -39,696.00
API Access

Adaptin Bio Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=APTN&period=max&api_key=YOUR_API_KEY